Abraxis Bioscience (NASDAQ: ABII) has reportedly retained Goldman Sachs and Lazard as it looks to sell itself, according to dealreporter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE